LYMPHOMA, B-CELL MARGINAL ZONE
Clinical trials for LYMPHOMA, B-CELL MARGINAL ZONE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, B-CELL MARGINAL ZONE trials appear
Sign up with your email to follow new studies for LYMPHOMA, B-CELL MARGINAL ZONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control CompletedThis early-stage study tests an experimental pill called LOXO-338 in 316 adults with advanced blood cancers like leukemia, lymphoma, or multiple myeloma. Participants have already tried standard treatments. The main goals are to find the safest dose and see if the drug shrinks tu…
Matched conditions: LYMPHOMA, B-CELL MARGINAL ZONE
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New pill shows promise for Hard-to-Treat leukemia and lymphoma
Disease control CompletedThis phase 2 study tested an oral drug called pirtobrutinib in 87 Chinese adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or non-Hodgkin lymphoma who had already received standard treatments. The goal was to see how well the drug shrank tumors and to check f…
Matched conditions: LYMPHOMA, B-CELL MARGINAL ZONE
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC